dual agonist glp 1 glucagon GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes Evaluation of biased agonism mediated
Description
GLP-1R agonists are typically combined with metformin or other antidiabetic drugs
doi: 10.1007/s13300-018-0377-5
95% CI 0.230.80)
The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021
doi: 10.1038/nm919
doi: 10.1210/endo.130.3.1371446
